Tobacco smoke exposure in pulmonary arterial and thromboembolic pulmonary hypertension

Respiration

Volumn 88, Issue 1, 2014, Pages 38-45

  Keusch, Stephan ^a   Hildenbrand, Florian F ^a   Bollmann, Tom ^b   Halank, Michael ^c   Held, Matthias ^d   Kaiser, Ralf ^e   Kovacs, Gabor ^h,i   Lange, Tobias J ^f   Seyfarth, Hans Jürgen ^g   Speich, Rudolf ^a   Ulrich, Silvia ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b UNIVERSITY OF GREIFSWALD   (Germany)

^c DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^d UNIVERSITY OF WÜRZBURG   (Germany)

^e SAARLAND UNIVERSITY   (Germany)

^f UNIVERSITY HOSPITAL REGENSBURG   (Germany)

^g UNIVERSITY OF LEIPZIG   (Germany)

^h UNIVERSITY OF GRAZ   (Austria)

ⁱ LUDWIG BOLTZMANN INSTITUTE FOR LUNG VASCULAR RESEARCH   (Austria)

Author keywords

Chronic thromboembolic pulmonary hypertension; Pulmonary arterial hypertension; Pulmonary hypertension; Risk factor; Smoking; Tobacco smoke

Indexed keywords

TOBACCO SMOKE; PASSIVE SMOKING;

ADULT; ARTICLE; CASE CONTROL STUDY; CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION; CONTROLLED STUDY; DISEASE ASSOCIATION; ENVIRONMENTAL EXPOSURE; FEMALE; FORCED VITAL CAPACITY; HEART RIGHT ATRIUM PRESSURE; HUMAN; LUNG DIFFUSION CAPACITY; LUNG WEDGE PRESSURE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PASSIVE SMOKING; PATHOGENESIS; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PULMONARY HYPERTENSION; SEX DIFFERENCE; SMOKING; VENOUS OXYGEN TENSION; ADVERSE EFFECTS; AGED; AUSTRIA; CLINICAL TRIAL; COMPLICATION; GERMANY; HYPERTENSION, PULMONARY; MIDDLE AGED; PULMONARY EMBOLISM; COMORBIDITY; FORCED EXPIRATORY VOLUME; OXYGEN SATURATION; RISK FACTOR;

AGED; AUSTRIA; CASE-CONTROL STUDIES; FEMALE; GERMANY; HUMANS; HYPERTENSION, PULMONARY; MALE; MIDDLE AGED; PULMONARY EMBOLISM; SMOKING; TOBACCO SMOKE POLLUTION;

EID: 84903523199     PISSN: 00257931     EISSN: 14230356     Source Type: Journal    
DOI: 10.1159/000359972     Document Type: Article

References (34)

1. Simonneau G, Robbins IM, Beghetti M, Channick RN, Delcroix M, Denton CP, Elliott CG, Gaine SP, Gladwin MT, Jing ZC, Krowka MJ, Langleben D, Nakanishi N, Souza R: Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol 2009; 54:S43-S54.
2. Eddahibi S, Morrell N, d'Ortho MP, Naeije R, Adnot S: Pathobiology of pulmonary arterial hypertension. Eur Respir J 2002; 20: 1559-1572.
3. Ulrich S, Hersberger M, Fischler M, Nussbaumer-Ochsner Y, Treder U, Russi EW, Speich R: Genetic polymorphisms of the serotonin transporter, but not the 2a receptor or nitric oxide synthetase, are associated with pulmonary hypertension in chronic obstructive pulmonary disease. Respiration 2010; 79: 288-295.
4. Wright JL, Tai H, Churg A: Cigarette smoke induces persisting increases of vasoactive mediators in pulmonary arteries. Am J Respir Cell Mol Biol 2004; 31: 501-509.
5. Wright JL, Farmer SG, Churg A: A neutrophil elastase inhibitor reduces cigarette smoke-induced remodelling of lung vessels. Eur Respir J 2003; 22: 77-81.
6. Barbera JA, Peinado VI, Santos S, Ramirez J, Roca J, Rodriguez-Roisin R: Reduced expression of endothelial nitric oxide synthase in pulmonary arteries of smokers. Am J Respir Crit Care Med 2001; 164: 709-713.
7. Santos S, Peinado VI, Ramirez J, Melgosa T, Roca J, Rodriguez-Roisin R, Barbera JA: Characterization of pulmonary vascular remodelling in smokers and patients with mild COPD. Eur Respir J 2002; 19: 632-638.
8. Schiess R, Senn O, Fischler M, Huber LC, Vatandaslar S, Speich R, Ulrich S: Tobacco smoke: a risk factor for pulmonary arterial hypertension? A case-control study. Chest 2010; 138: 1086-1092.
9. Grunig E, Barner A, Bell M, Claussen M, Dandel M, Dumitrescu D, Gorenflo M, Holt S, Kovacs G, Ley S, Meyer JF, Pabst S, Riemekasten G, Saur J, Schwaiblmair M, Seck C, Sinn L, Sorichter S, Winkler J, Leuchte HH: Noninvasive diagnosis of pulmonary hypertension: ESC/ERS Guidelines with commentary of the Cologne Consensus Conference 2010 (in German). Dtsch Med Wochenschr 2010; 135(suppl 3):S67-S77.
10. Jha P, Ramasundarahettige C, Landsman V, Rostron B, Thun M, Anderson RN, McAfee T, Peto R: 21st-century hazards of smoking and benefits of cessation in the United States. N Engl J Med 2013; 368: 341-350.
11. Samanek M, Aviado DM: Cardiopulmonary effects of tobacco and related substances. 3. Pulmonary vascular effects of cigarette smoke and nicotine. Arch Environ Health 1966; 12: 717-724.
12. Wright JL, Churg A: Effect of long-term cigarette smoke exposure on pulmonary vascular structure and function in the guinea pig. Exp Lung Res 1991; 17: 997-1009.
13. Sekhon HS, Wright JL, Churg A: Cigarette smoke causes rapid cell proliferation in small airways and associated pulmonary arteries. Am J Physiol 1994; 267:L557-L563.
14. Hale KA, Ewing SL, Gosnell BA, Niewoehner DE: Lung disease in long-term cigarette smokers with and without chronic air-flow obstruction. Am Rev Respir Dis 1984; 130: 716-721.
15. Peinado VI, Barbera JA, Abate P, Ramirez J, Roca J, Santos S, Rodriguez-Roisin R: Inflammatory reaction in pulmonary muscular arteries of patients with mild chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999; 159: 1605-1611.
16. Yamato H, Sun JP, Churg A, Wright JL: Guinea pig pulmonary hypertension caused by cigarette smoke cannot be explained by capillary bed destruction. J Appl Physiol 1997; 82: 1644-1653.
17. Seimetz M, Parajuli N, Pichl A, Veit F, Kwapiszewska G, Weisel FC, Milger K, Egemnazarov B, Turowska A, Fuchs B, Nikam S, Roth M, Sydykov A, Medebach T, Klepetko W, Jaksch P, Dumitrascu R, Garn H, Voswinckel R, Kostin S, Seeger W, Schermuly RT, Grimminger F, Ghofrani HA, Weissmann N: Inducible NOS inhibition reverses tobaccosmoke-induced emphysema and pulmonary hypertension in mice. Cell 2011; 147: 293-305.
18. Wright JL, Tai H, Churg A: Vasoactive mediators and pulmonary hypertension after cigarette smoke exposure in the guinea pig. J Appl Physiol 2006; 100: 672-678.
19. Wright JL, Churg A: Short-term exposure to cigarette smoke induces endothelial dysfunction in small intrapulmonary arteries: analysis using guinea pig precision cut lung slices. J Appl Physiol 2008; 104: 1462-1469.
20. Bearer C, Emerson RK, O'Riordan MA, Roitman E, Shackleton C: Maternal tobacco smoke exposure and persistent pulmonary hypertension of the newborn. Environ Health Perspect 1997; 105: 202-206.
21. Flouris AD, Vardavas CI, Metsios GS, Tsatsakis AM, Koutedakis Y: Biological evidence for the acute health effects of secondhand smoke exposure. Am J Physiol Lung Cell Mol Physiol 2010; 298:L3-L12.
22. Hamer M, Stamatakis E, Kivimaki M, Lowe GD, Batty GD: Objectively measured secondhand smoke exposure and risk of cardiovascular disease: what is the mediating role of inflammatory and hemostatic factors? J Am Coll Cardiol 2010; 56: 18-23.
23. Eisner MD, Wang Y, Haight TJ, Balmes J, Hammond SK, Tager IB: Secondhand smoke exposure, pulmonary function, and cardiovascular mortality. Ann Epidemiol 2007; 17: 364-373.
24. Churg A, Wang RD, Wright JL: Cigarette smoke causes small airway remodeling by direct growth factor induction and release. Proc Am Thorac Soc 2006; 3: 493.
25. Zang EA, Wynder EL: Differences in lung cancer risk between men and women: examination of the evidence. J Natl Cancer Inst 1996; 88: 183-192.
26. Kirkpatrick dP, Dransfield MT: Racial and sex differences in chronic obstructive pulmonary disease susceptibility, diagnosis, and treatment. Curr Opin Pulm Med 2009; 15: 100-104.
27. Sin DD, Cohen SB, Day A, Coxson H, Pare PD: Understanding the biological differences in susceptibility to chronic obstructive pulmonary disease between men and women. Proc Am Thorac Soc 2007; 4: 671-674.
28. Ben-Zaken Cohen S, Pare PD, Man SF, Sin DD: The growing burden of chronic obstructive pulmonary disease and lung cancer in women: examining sex differences in cigarette smoke metabolism. Am J Respir Crit Care Med 2007; 176: 113-120.
29. Sertogullarindan B, Gumrukcuoglu HA, Sezgi C, Akil MA: Frequency of pulmonary hypertension in patients with COPD due to biomass smoke and tobacco smoke. Int J Med Sci 2012; 9: 406-412.
30. Trip P, Nossent EJ, de Man FS, van den Berk IA, Boonstra A, Groepenhoff H, Leter EM, Westerhof N, Grunberg K, Bogaard HJ, Vonk Noordegraaf A: Severely reduced diffusion capacity in idiopathic pulmonary arterial hypertension-patient characteristics and treatment responses. Eur Respir J 2013; 42: 1575-1585.
31. Laveneziana P, Garcia G, Joureau B, Nicolas-Jilwan F, Brahimi T, Laviolette L, Sitbon O, Simonneau G, Humbert M, Similowski T: Dynamic respiratory mechanics and exertional dyspnoea in pulmonary arterial hypertension. Eur Respir J 2013; 41: 578-587.
32. Meyer FJ, Ewert R, Hoeper MM, Olschewski H, Behr J, Winkler J, Wilkens H, Breuer C, Kubler W, Borst MM: Peripheral airway obstruction in primary pulmonary hypertension. Thorax 2002; 57: 473-476.
33. Chaouat A, Naeije R, Weitzenblum E: Pulmonary hypertension in COPD. Eur Respir J 2008; 32: 1371-1385.
34. Chaouat A, Bugnet AS, Kadaoui N, Schott R, Enache I, Ducolone A, Ehrhart M, Kessler R, Weitzenblum E: Severe pulmonary hypertension and chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2005; 172: 189-194.